Oxurion NV: Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
Source: finanznachrichten.de
Stay updated with breaking news from Regulated Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinancialContent fully hosted finance channel
UNIBIOS HOLDINGS LIMITED announces, after relevant notification, the following Regulated Information: Mr. Orfeas Mavrikios, Managing Director of our company,... | May 24, 2023
Announcement of Regulated Information - Notification of Substantial Holdings Announcement of Regulated Information - Notification of Substantial Holdings ... | May 24, 2023